BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $150,017 | -51.2% | 3,975 | -41.1% | 0.01% | -50.0% |
Q2 2023 | $307,555 | +14.7% | 6,750 | +2.1% | 0.01% | +11.1% |
Q1 2023 | $268,221 | +58.0% | 6,612 | +98.6% | 0.01% | +28.6% |
Q4 2022 | $169,715 | -32.7% | 3,329 | -28.9% | 0.01% | -41.7% |
Q3 2022 | $252,000 | -21.2% | 4,680 | -6.0% | 0.01% | -20.0% |
Q2 2022 | $320,000 | -28.7% | 4,981 | -11.9% | 0.02% | -16.7% |
Q1 2022 | $449,000 | -29.2% | 5,657 | -23.4% | 0.02% | -25.0% |
Q4 2021 | $634,000 | +12.0% | 7,384 | +5.0% | 0.02% | +4.3% |
Q3 2021 | $566,000 | +3.3% | 7,033 | +3.3% | 0.02% | 0.0% |
Q2 2021 | $548,000 | +8.3% | 6,810 | +13.6% | 0.02% | -4.2% |
Q1 2021 | $506,000 | +11.7% | 5,997 | +6.1% | 0.02% | -4.0% |
Q4 2020 | $453,000 | -4.6% | 5,652 | -4.4% | 0.02% | -13.8% |
Q3 2020 | $475,000 | -10.5% | 5,912 | -4.2% | 0.03% | -17.1% |
Q2 2020 | $531,000 | +2.9% | 6,174 | -3.0% | 0.04% | -16.7% |
Q1 2020 | $516,000 | +5.7% | 6,363 | +9.0% | 0.04% | +13.5% |
Q4 2019 | $488,000 | -20.3% | 5,836 | -16.6% | 0.04% | -28.8% |
Q3 2019 | $612,000 | +9.9% | 6,994 | +2.9% | 0.05% | -3.7% |
Q2 2019 | $557,000 | 0.0% | 6,798 | -0.8% | 0.05% | -14.3% |
Q1 2019 | $557,000 | +18.3% | 6,854 | -4.3% | 0.06% | -4.5% |
Q4 2018 | $471,000 | -12.9% | 7,160 | +1.9% | 0.07% | -1.5% |
Q3 2018 | $541,000 | +4.4% | 7,024 | +0.0% | 0.07% | -9.5% |
Q2 2018 | $518,000 | +8.6% | 7,023 | -4.3% | 0.07% | 0.0% |
Q1 2018 | $477,000 | -5.0% | 7,338 | -5.5% | 0.07% | -9.8% |
Q4 2017 | $502,000 | +0.4% | 7,761 | 0.0% | 0.08% | -4.7% |
Q3 2017 | $500,000 | +4.4% | 7,761 | -2.1% | 0.09% | -4.4% |
Q2 2017 | $479,000 | -44.8% | 7,928 | -48.9% | 0.09% | +4.7% |
Q1 2017 | $868,000 | +416.7% | 15,516 | +310.6% | 0.09% | +120.5% |
Q4 2016 | $168,000 | – | 3,779 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |